(Q44151701)

30 November 2017

How HIV treatment advances affect the cost-effectiveness of prevention (English)

1 reference

30 November 2017

prevention of HIV/AIDS

0 references

author name string

S D Pinkerton

series ordinal

1

1 reference

PubMed ID

10638541

30 November 2017

D R Holtgrave

series ordinal

2

1 reference

30 November 2017

1 January 2000

1 reference

30 November 2017

Medical Decision Making

1 reference

30 November 2017

20

1 reference

30 November 2017

1

1 reference

30 November 2017

89-94

1 reference

Economic evaluation of HIV prevention programs

30 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0002000111

Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0002000111

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0002000111

Cost-effectiveness of a community-level HIV risk reduction intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0002000111

HIV-1 diversity in Romania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X0002000111

10.1177/0272989X0002000111

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

10638541